Catalent launches new kit labeling system to reduce 'risk of human error'

By Melissa Fassbender

- Last updated on GMT

Peel-ID seeks to reduce a patient’s risk of receiving the incorrect medication at clinical sites. (Image: iStock/Kwangmoozaa)
Peel-ID seeks to reduce a patient’s risk of receiving the incorrect medication at clinical sites. (Image: iStock/Kwangmoozaa)

Related tags Pharmacology Patient

Catalent Pharma Solutions has released a new clinical supply labeling tool in response to a "work-around" which could put patients' safety at risk.

According to Steve McMahon, Operations Manager, Clinical Supply Services at Catalent, the new system was developed in response to clinical sites that would manually write kit identification numbers on an unlabelled package’s side, because the original label becomes obscured due to the way kits are stored.

The manual writing of kit identification numbers, which is a work-around by the clinical staff to address this issue, may hinder the efficiency and accuracy of the storage and distribution process, while posing a risk to patient safety​,” McMahon told Outsourcing-Pharma.com.

The new system, Peel-ID seeks to reduce a patient’s risk of receiving the incorrect medication at clinical sites.

By using a Peel-ID label, the risk of human error resulting from the incorrect kit being pulled from inventory due to illegible handwriting or incorrectly transposed characters is greatly reduced​,” he added.

McMahon explained that kits are typically labelled on their largest face, however depending on how a clinical site’s storage area is arranged, the label by not be visible while the kit is sitting on a shelf of in a drawer.

Our clinical site liaisons recognized the potential for harm from this practice and engaged our employees to develop an innovative and practical solution​,” said Esther Sadler-Williams, Global Director Strategic Development and Innovation at Catalent. “Peel-ID will now be our standard recommendation to customers for all patient kits packaged by Catalent, reducing risks to patient safety​.”

The patent pending clinical label features a permanent portion and a peel-off label containing the patient kit identifier, which can be removed by site personnel and attached elsewhere on the patient kit.

Related news

Show more

Related products

show more

Unlock potential in buffer preparation

Unlock potential in buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 18-Sep-2023 | Infographic

Consider how the right partner can help you scale faster, mitigate risks, and optimize resources.

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 14-Aug-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Automated metadata management in clinical trials

Automated metadata management in clinical trials

Content provided by Formedix | 01-Aug-2023 | White Paper

When it comes to efficient clinical study build, content is king. Most importantly: metadata content. In this blog, we explore the role of metadata in...

Related suppliers

Follow us

Products

View more

Webinars